Literature DB >> 23180036

Complement in antineutrophil cytoplasmic antibody-associated vasculitis.

Jun Yuan1,2,3,4,5,6,7, Min Chen8,9,10,11,12, Ming-Hui Zhao1,2,3,4,5.   

Abstract

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is a group of autoimmune disorders. It was previously assumed that the complement system is not involved in the development of ANCA-associated vasculitis due to its "pauci-immune" feature in renal histology. However, increasing evidence indicates that activation of the complement system, especially via the alternative complement pathway, plays a crucial role in the pathogenesis of ANCA-associated vasculitis. In this brief review, we discuss the evidence, including in vivo, in vitro, and clinical studies, for complement system activation in ANCA-associated vasculitis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23180036     DOI: 10.1007/s10157-012-0700-9

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  21 in total

1.  Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.

Authors:  Hong Xiao; Adrian Schreiber; Peter Heeringa; Ronald J Falk; J Charles Jennette
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells.

Authors:  I Olsson; P Venge
Journal:  Blood       Date:  1974-08       Impact factor: 22.113

3.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.

Authors:  R J Falk; R S Terrell; L A Charles; J C Jennette
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Complement alternative pathway acts as a positive feedback amplification of neutrophil activation.

Authors:  Laurent Camous; Lubka Roumenina; Sylvain Bigot; Soumeya Brachemi; Véronique Frémeaux-Bacchi; Philippe Lesavre; Lise Halbwachs-Mecarelli
Journal:  Blood       Date:  2010-11-09       Impact factor: 22.113

5.  C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.

Authors:  Adrian Schreiber; Hong Xiao; J Charles Jennette; Wolfgang Schneider; Friedrich C Luft; Ralph Kettritz
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

Review 6.  Functions of C5a receptors.

Authors:  Peter A Ward
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

Review 7.  Anti-neutrophil cytoplasmic antibody pathogenesis in small-vessel vasculitis: an update.

Authors:  José A Gómez-Puerta; Xavier Bosch
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

Review 8.  Complement component 5a (C5a).

Authors:  Helga D Manthey; Trent M Woodruff; Stephen M Taylor; Peter N Monk
Journal:  Int J Biochem Cell Biol       Date:  2009-04-11       Impact factor: 5.085

Review 9.  New insights of an old defense system: structure, function, and clinical relevance of the complement system.

Authors:  Christian Ehrnthaller; Anita Ignatius; Florian Gebhard; Markus Huber-Lang
Journal:  Mol Med       Date:  2010-10-29       Impact factor: 6.354

10.  p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation.

Authors:  Jian Hao; Li-Qiang Meng; Peng-Cheng Xu; Min Chen; Ming-Hui Zhao
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

View more
  3 in total

1.  Alternative complement pathway activation products in urine and kidneys of patients with ANCA-associated GN.

Authors:  Shen-Ju Gou; Jun Yuan; Chen Wang; Ming-Hui Zhao; Min Chen
Journal:  Clin J Am Soc Nephrol       Date:  2013-10-10       Impact factor: 8.237

Review 2.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

3.  The association of low complement with disease activity in systemic sclerosis: a prospective cohort study.

Authors:  James Esposito; Zoe Brown; Wendy Stevens; Joanne Sahhar; Candice Rabusa; Jane Zochling; Janet Roddy; Jennifer Walker; Susanna M Proudman; Mandana Nikpour
Journal:  Arthritis Res Ther       Date:  2016-10-22       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.